Research and Markets: Nanobiotechnology Applications, Markets and Companies - the Newly Updated Report Sees Nanotechnology Being Applied to All Stages of Drug Development from Formulations to Diagnostic Applications

DUBLIN--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/310367/nanobiotechnology) has
announced the addition of Jain PharmaBiotech's new report "Nanobiotechnology
Applications, Markets and Companies" to their offering.

Nanotechnology is the creation and utilization of materials, devices, and
systems through the control of matter on the nanometer-length scale (a nanometer
is one billionth of a meter). Nanobiotechnology, an integration of physical
sciences, molecular engineering, biology, chemistry and biotechnology holds
considerable promise of advances in pharmaceuticals and healthcare. The report
starts with an introduction to various techniques and materials that are
relevant to nanobiotechnology. It includes some of the physical forms of energy
such as nanolasers. Some of the technologies are scaling down such as
microfluidics to nanofluidic biochips and others are constructions from bottom
up. Application in life sciences research, particularly at the cell level sets
the stage for role of nanobiotechnology in healthcare in subsequent chapters.

Some of the earliest applications are in molecular diagnostics. Nanoparticles,
particularly quantum dots, are playing important roles. In vitro diagnostics,
does not have any of the safety concerns associated with the fate of
nanoparticles introduced into the human body. Numerous nanodevices and
nanosystems for sequencing single molecules of DNA are feasible. Various
nanodiagnostics that have been reviewed will improve the sensitivity and extend
the present limits of molecular diagnostics.

An increasing use of nanobiotechnology by the pharmaceutical and biotechnology
industries is anticipated. Nanotechnology will be applied at all stages of drug
development from formulations for optimal delivery to diagnostic applications in
clinical trials. Many of the assays based on nanobiotechnology will enable
high-throughput screening. Some of nanostructures such as fullerenes are
themselves drug candidates as they allow precise grafting of active chemical
groups in three-dimensional orientations. The most important pharmaceutical
applications are in drug delivery. Apart from offering a solution to solubility
problems, nanobiotechnology provides and intracellular delivery possibilities.
Skin penetration is improved in transdermal drug delivery. A particularly
effective application is as nonviral gene therapy vectors. Nanotechnology has
the potential to provide controlled release devices with autonomous operation
guided by the needs.

Nanomedicine is now within the realm of reality starting with nanodiagnostics
and drug delivery facilitated by nanobiotechnology. Miniature devices such as
nanorobots could carry out integrated diagnosis and therapy by refined and
minimally invasive procedures, nanosurgery, as an alternative to crude surgery.
Nanotechnology will markedly improve the implants and tissue engineering
approaches as well.

There is some concern about the safety of nanoparticles introduced in the human
body and released into the environment. Research is underway to address these
issues. As yet there are no FDA directives to regulate nanobiotechnology but as
products are ready to enter market, these are expected to be in place.

Future nanobiotechnology markets are calculated on the basis of the background
markets in the areas of application and the share of this market by new
technologies and state of development at any given year in the future. This is
based on a comprehensive and thorough review of the current status of
nanobiotechnology, research work in progress and anticipated progress. There is
definite indication of large growth of the market but it will be uneven and
cannot be plotted as a steady growth curve. Marketing estimates are given
according to areas of application, technologies and geographical distribution
starting with 2008. The largest expansion is expected between the years 2013 and
2018.

Profiles of 242 companies, out of over 500 involved in this area, are included
in the last chapter along with their 189 collaborations. The report is
supplemented with 39 Tables, 21 figures and 700 references to the literature.

The Key Topics Covered:

Executive Summary

1. Basics of Nanobiotechnology

2. Technologies

3. Applications in Life Sciences

4. Nanomolecular Diagnostics

5. Nanobiotechnology in Drug Discovery & Development

6. Nanobiotechnology in Drug Delivery

7. Clinical Applications of Nanobiotechnology

8. Ethical, Safety and Regulatory issues

9. Nanobiotechnology Markets

10. Nanobiotech Companies

To view a more detailed Table of Contents and for more information on this
report visit
http://www.researchandmarkets.com/research/310367/nanobiotechnology

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Copyright Business Wire 2009